Synonyms: Soluble suppression of tumorigenicity 2
Sample Type
Serum, Plasma
Assay Range
6 - 0.188 ng/ml
Description
Enzyme Immunoassay for the quantitative determination sST2 in human serum and plasma.
sST2 (Soluble suppression of tumorigenicity 2) is a member of the Interleukin-1 receptor family. Like other ligands in the IL-1 family, the binding of IL-33 and ST2L on the inflammatory cell membrane activates subsequent intracellular signalling and mediates its pro-inflammatory action. It is raised in various cardiovascular diseases. sST2 significantly predicts disease severity and mortality in cardiovascular disease and is a good predictor of mortality in patients with stable coronary artery disease and chronic heart failure.
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).